Mab Facilities Management, L.L.C.

Mab Facilities Management, L.L.C. company information, Employees & Contact Information

MAB Facilities Management is a total facilities service provider of choice in the Middle East and North Africa region, delivering best-value services in FM consultancy, managing agent, engineering maintenance, cleaning, security, concierge, pools management, and landscaping to discerning clients. Our properties services include high / low rise residential and commercial towers, large residential communities, retail, leisure, entertainment and data centers. we are proud to have: - A certification in Quality Management System(ISO 9001), Environmental Management System (ISO 14001), Energy Management System( ISO 50001) and Occupational Health & Safety Management System(OHSAS 18001) and also a training/assessment center accredited by BICSc. - BICSc membership and accreditation for training/assessment center. - IPSA membership.

Company Details

Employees
850
Founded
-
Address
702, Shangri-La Office Towers, Dubai,dubai 00000,united Arab Emirates
Phone
+971 800 275 622
Email
info@mab.ae
Industry
Facilities Services
NAICS
Facilities Support Services
HQ
Dubai, Dubai
Looking for a particular Mab Facilities Management, L.L.C. employee's phone or email?

Mab Facilities Management, L.l.c. Questions

News

I-Mab undergoes makeover, with new name, strategy, asset and Hong Kong IPO plans - Fierce Biotech

I-Mab undergoes makeover, with new name, strategy, asset and Hong Kong IPO plans Fierce Biotech

Regional and Thematic Networks - unesco.org

Regional and Thematic Networks unesco.org

Novo Nordisk to advance ATTR amyloidosis mAb to Phase III - Clinical Trials Arena

Novo Nordisk to advance ATTR amyloidosis mAb to Phase III Clinical Trials Arena

Cutting mAb Production Costs via Tech, Automation, and AI - Genetic Engineering and Biotechnology News

Cutting mAb Production Costs via Tech, Automation, and AI Genetic Engineering and Biotechnology News

I-Mab lays off 27% of workforce after pivoting to CLDN18.2 bispecific - Fierce Biotech

I-Mab lays off 27% of workforce after pivoting to CLDN18.2 bispecific Fierce Biotech

Machine-learning potentials for structurally and chemically complex MAB phases: Strain hardening and ripplocation-mediated plasticity - ScienceDirect.com

Machine-learning potentials for structurally and chemically complex MAB phases: Strain hardening and ripplocation-mediated plasticity ScienceDirect.com

I-Mab bets on a Bristol buy-in | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

I-Mab bets on a Bristol buy-in | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Former WLBT general manager given MAB award, current general manager named president of MAB - WLBT

Former WLBT general manager given MAB award, current general manager named president of MAB WLBT

Mab.io Launches Opinionated Project Management Platform to Streamline Workflows and Boost Team Efficiency - Yahoo Finance

Mab.io Launches Opinionated Project Management Platform to Streamline Workflows and Boost Team Efficiency Yahoo Finance

Latent EBV enhances the efficacy of anti-CD3 mAb in Type 1 diabetes - Nature

Latent EBV enhances the efficacy of anti-CD3 mAb in Type 1 diabetes Nature

IMGT/mAb-KG: the knowledge graph for therapeutic monoclonal antibodies - Frontiers

IMGT/mAb-KG: the knowledge graph for therapeutic monoclonal antibodies Frontiers

Why Studies Often Miss Adverse Effects - MedCentral

Why Studies Often Miss Adverse Effects MedCentral

I-Mab Announces the Appointment of Seasoned Biotech - GlobeNewswire

I-Mab Announces the Appointment of Seasoned Biotech GlobeNewswire

I-Mab Reports Second Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance

I-Mab Reports Second Quarter 2025 Financial Results and Provides Business Update Yahoo Finance

Continuous Manufacturing Helps mAb Firms Innovate and Cut Costs - Genetic Engineering and Biotechnology News

Continuous Manufacturing Helps mAb Firms Innovate and Cut Costs Genetic Engineering and Biotechnology News

Everest Medicines Expands Strategic Investment in I-MAB - Yahoo Finance

Everest Medicines Expands Strategic Investment in I-MAB Yahoo Finance

I-Mab buys Bridge Health for $3M-plus to strengthen pivot to CLDN18.2 bispecific - Fierce Biotech

I-Mab buys Bridge Health for $3M-plus to strengthen pivot to CLDN18.2 bispecific Fierce Biotech

Time to Intensify: Taking Process Intensification of mAb Manufacturing to the Next Level - Genetic Engineering and Biotechnology News

Time to Intensify: Taking Process Intensification of mAb Manufacturing to the Next Level Genetic Engineering and Biotechnology News

I-Mab (IMAB) Shows 83% Response Rate for Givastomig in Metastatic Gastric Cancer - Yahoo Finance

I-Mab (IMAB) Shows 83% Response Rate for Givastomig in Metastatic Gastric Cancer Yahoo Finance

I-Mab Announces Acceleration of Givastomig Investment and Leadership Appointments - Yahoo Finance

I-Mab Announces Acceleration of Givastomig Investment and Leadership Appointments Yahoo Finance

I-Mab Announces Pricing of $65 Million Underwritten Offering of American Depositary Shares - GlobeNewswire

I-Mab Announces Pricing of $65 Million Underwritten Offering of American Depositary Shares GlobeNewswire

I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer - PR Newswire

I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer PR Newswire

Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial - Nature

Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial Nature

Understanding the Stabilizing Effect of Histidine on mAb Aggregation: A Molecular Dynamics Study - ACS Publications

Understanding the Stabilizing Effect of Histidine on mAb Aggregation: A Molecular Dynamics Study ACS Publications

Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections - Nature

Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections Nature

Remembering Raw Material Basics for mAb Production - BioPharm International

Remembering Raw Material Basics for mAb Production BioPharm International

Complex mAb Purification: Challenges and Solutions - Genetic Engineering and Biotechnology News

Complex mAb Purification: Challenges and Solutions Genetic Engineering and Biotechnology News

Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus - The New England Journal of Medicine

Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus The New England Journal of Medicine

I-Mab sheds China footprint to complete transformation into US-based biotech - Fierce Biotech

I-Mab sheds China footprint to complete transformation into US-based biotech Fierce Biotech

I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers - PR Newswire

I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers PR Newswire

Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer - The New England Journal of Medicine

Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer The New England Journal of Medicine

MAB Young Scientists Award - Unric

MAB Young Scientists Award Unric

Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma - The New England Journal of Medicine

Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma The New England Journal of Medicine

Scale-Up of Twin-Column Periodic Countercurrent Chromatography for MAb Purification - BioProcess International

Scale-Up of Twin-Column Periodic Countercurrent Chromatography for MAb Purification BioProcess International

Agonist anti-ChemR23 mAb reduces tissue neutrophil accumulation and triggers chronic inflammation resolution - Science | AAAS

Agonist anti-ChemR23 mAb reduces tissue neutrophil accumulation and triggers chronic inflammation resolution Science | AAAS

Man and the Biosphere Programme (MAB) - unesco.org

Man and the Biosphere Programme (MAB) unesco.org

Stability enhancement in a mAb and Fab coformulation - Nature

Stability enhancement in a mAb and Fab coformulation Nature

Industrialization of mAb production technology: The bioprocessing industry at a crossroads - Taylor & Francis Online

Industrialization of mAb production technology: The bioprocessing industry at a crossroads Taylor & Francis Online

Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma - Nature

Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma Nature

Good Practices - en.unesco.org

Good Practices en.unesco.org

MAB Youth - en.unesco.org

MAB Youth en.unesco.org

Man and the Biosphere (MAB) Programme - en.unesco.org

Man and the Biosphere (MAB) Programme en.unesco.org

About the Man and the Biosphere (MAB) Programme - unesco.org

About the Man and the Biosphere (MAB) Programme unesco.org

A new approach to quantification of mAb aggregates using peptide affinity probes - Nature

A new approach to quantification of mAb aggregates using peptide affinity probes Nature

Standardized Economic Cost Modeling for Next-Generation MAb Production - BioProcess International

Standardized Economic Cost Modeling for Next-Generation MAb Production BioProcess International

Top Mab Facilities Management, L.L.C. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant